CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · Real-Time Price · USD

0.9507

-0.0593 (-5.87%)

At close: Apr 24, 2026, 4:00 PM EDT

0.9000

-0.0507 (-5.33%)

After-hours: Apr 24, 2026, 5:54 PM EDT

Revenue by Segment

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Immune Cell Therapy		1.00	113.84K	59.47K
Immune Cell Therapy Growth		-100.00%	91.43%	-
Total		1.00	113.84K	59.47K
Total Growth		-100.00%	91.43%	-

Source: S&P Global Market Intelligence.